Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation.

Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation. Clin Cancer Res. 2022 09 01; 28(17):3669-3676.

View in: PubMed

subject areas

B7-H1 Antigen
Breast Neoplasms
Female
Fluorescent Antibody Technique
Germ-Line Mutation
Humans
Lymphocytes, Tumor-Infiltrating
Neoadjuvant Therapy
Phthalazines
Pilot Projects
Poly(ADP-ribose) Polymerase Inhibitors
Programmed Cell Death 1 Receptor
Staining and Labeling
Tumor Microenvironment

authors with profiles

JENNIFER LITTON
MARION ELIZABETH SCOGGINS
GARY J WHITMAN
BANU K ARUN
BEATRIZ ELENA ADRADA
ELIZABETH ANN MITTENDORF
HAVEN REBECCA GARBER
YILING LU
ALEJANDRO CONTRERAS